Introduction: One of the reasons for difficulty with walking in people with multiple sclerosis (PwMS) is foot drop; the inability to dorsiflex the ankle during the swing phase of the gait. One approach to correct foot drop is to passively support the ankle joint with an ankle foot orthosis (AFO) or a foot up splint. Another approach is to use functional electrical stimulation (FES).
INTRODUCTION
Multiple sclerosis is an inflammatory disease causing demyelination of the central nervous system. It is the most common progressive neurological condition affecting young adults with a prevalence of 100 to 120 in every 100,000 adults in the United Kingdom. Only 18% of the PwMS were able to walk for 10 m without limping. 1 In a survey on perceptions of body functions, PwMS gave highest priority to lower limb functions. 2 One of the reasons for difficulty with walking in PwMS is foot drop; the inability to dorsiflex the ankle during the swing phase of the gait. One approach to correct foot drop is to passively support the ankle joint with an AFO or a foot up splint. Another approach is to use FES. The FES has a heel-switch worn in the patient's shoe, positioned under the heel. This switch activates electrodes placed over the common peroneal nerve at the head of the fibula during the swing phase. Stimulation will cause dorsiflexion of the ankle and foot clearance. This device enables patients with foot drop due to MS to walk without tripping. The FES is approved by NICE for correcting foot drop in upper motor neuron conditions like MS. A meta-analysis of trials in patients with stroke showed that FES improved walking speed by 38%. 3 Patient compliance with FES is 86%. 4 The effects of FES on gait are: the orthotic effects (change in walking with and without FES) and therapeutic effects (the effect of regular use of FES on walking performance without FES). Given the potential for FES to improve mobility for PwMS and provide a cost-effective alternative to the current standard care, there is need for a comprehensive review of evidence of this intervention. This systematic review evaluated the evidence on use of FES to correct IJPMR foot drop in PwMS. The question for the systematic review was: "How effective is FES in improving gait in PwMS?"
MATERIAlS AND METHODS
We aimed to include all published RCT, non-RCTs, and case series exploring the effectiveness of FES on gait of PwMS. We included the studies with participants more than 18 years of age with foot drop due to MS and used FES as one of the interventions. We included the studies using walking-related outcome measures, such as speed of walking, falls, gait analysis, and energy expenditure for walking. Only studies published in English were included as we did not have funding for obtaining translations from other languages.
Search Strategy
Databases searched were AMED, EMBASE, BNI, MEDLINE, and CINAHL from 2005 till June 2015. The keywords used were shown in Table 1 .
Screening for Inclusion
We initially screened the titles of all search results and excluded repeated results, articles dealing with use of FES for indications other than foot drop, conference abstracts, and articles in languages other than English. Abstracts of the relevant articles were obtained and read. We further excluded nonsystematic reviews, expert opinions, editorials, and technical reviews. We obtained the full text of all the articles dealing with FES for foot drop.
Evaluation of the Evidence
Two reviewers read all the full-text articles independently and assessed the quality of the studies using the Physiotherapy Evidence Database (PEDro) scale. 5 Two reviewers then met and discussed the scores. The final scores were obtained in this meeting through consensus between the two reviewers. Studies with PEDro score of <4 were classified as poor in quality and were excluded. 6 The strength of the evidence was classified from 1 to 5 based on the Muir's hierarchy of the evidences shown in Table 2 .
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RESUlTS
From the search 172 articles were identified (Flow Chart 1). We excluded 130 results after reading the titles (duplicate results, not in English, on FES cycling, FES for improving muscle bulk, and FES for swallowing). Forty-two abstracts were reviewed and a further 27 were excluded (conference abstracts, nonsystematic reviews, opinions). Full texts of 15 articles were obtained and 13 were analyzed using the PEDro scale. The scores could not be done for a study using focused interviews. 8 There were three RCTs, eight non-RCTs, one large retrospective case series, two case series, and one meta-analysis. The PEDro scores of the 13 articles varied from 3 to 11 (Table 3) . [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] The reasons for the low scores on PEDro scale were a lack of randomization-12, absence of concealed 
Speed of Walking
The search revealed two RCTs on FES for foot drop in PwMS with an orthotic effect on speed of walking. 23 There is level-1 evidence on effectiveness of FES as an orthotic device in improving speed of walking.
Energy Expenditure of Walking
Two non-RCTs investigated the physiological cost of walking in PwMS. 9, 22 The use of FES led to a significant reduction in the physiological cost of gait. These studies provided level-3 evidence that FES improves energy expenditure for walking in PwMS. A qualitative study by Bulley et al 8 also found that patients reported reduced fatigue and falls with FES.
Gait Analysis
Scott et al 15 found that FES increased dorsiflexion at ankle, knee flexion, and reduced risk of knee hyperextension at initial contact (level-3). van der Linden et al 17, 19 showed longer stride length and better dorsiflexion of ankle during swing with FES (level-3). There is level-3 evidence that FES improves kinematics of gait, especially ankle dorsiflexion (Table 4) .
15,17,19

Falls
Barrett et al 10 in an RCT found that participants in the FES group experienced 72% fewer falls than in the control group (level-2). Esnouf et al 11 also reported that the median number of falls was significantly lower (p = 0.036) in FES IJPMR group compared to the exercise only group (level-2). In a cross-over trial, Taylor et al 16 noted that 83% of falls experienced over the study period occurred at times when FES was not being used (level-2). Bulley et al 8 did a qualitative study to explore the impact of FES (n = 6) and AFO (n = 4) on PwMS. Participants of the focus groups described fewer falls for both FES and AFO (level-4). There is level-2 evidence that FES reduced falls in PwMS (Table 4) .
Activities of Daily living
Esnouf et al 11 studied the impact of FES on activities of daily living in 53 PwMS. Authors noted greater "improvements" in performance and satisfaction scores in the FES group than the exercise group. They concluded that the "use of the FES improved performance in activities of daily living PwMS (level-2)."
Quality of life
Two non-RCTs reported that FES reduced the impact of MS and improved quality of life of PwMS (Table 3) .
18,21
Comparison of FES with AFO
There are three studies comparing AFO and FES for PwMS. Sheffler et al found that in three out of four subjects, FES resulted in more dorsiflexion at ankle compared to AFO. There were no differences in the speed of walking (level-3). 12 Street et al 20 noted that among 67 PwMS who were using FES, 27 had tried and rejected AFOs. Bulley et al 8 did a qualitative study to explore the impact of FES (n = 6) and AFO (n = 4) on PwMS. Participants of the focus groups described similar positive effects for both FES and AFO.
Cost-effectiveness of FES
One study with a sample of 39 PwMS demonstrated cost effectiveness, but has applied the same quality-adjusted life-year (QALY) gain from stroke for MS. The authors assumed that the QALY gain for MS is the same as in stroke. There are no other studies on the cost effectiveness of AFO.
24
DISCUSSION
The PEDro scores of the studies included were low. Only three studies randomized the participants. 10, 11, 16 All three were from the same center, making it difficult to generalize the results to other centers. None of the studies blinded the participants. Only one study used partly blinded assessors. 16 None of the studies used intentionto-treat analysis. More than 15% of the recruited patients dropped out in two of the three RCTs. 10, 11 Two RCTs provided level-2 evidence that speed of walking with FES was significantly better than the speed of walking without FES in PwMS. 10, 16 The speed of walking with and without FES was a secondary outcome measure in one trial. 10 The other one was a feasibility trial and was not designed to calculate the effect of the interventions. The trial also used multiple interventions which may have had a carry-over effect. 16 Five non-RCTs also reported that FES increased speed of walking in PwMS in a clinical setting. 9, 12, 18, 19, 21 A large pragmatic study reflecting the routine clinical use of FES in PwMS also reported significant. The two major limitations of this study are the lack of randomization and absence of a control group. 20 There is level-2 and level-3 evidences that FES work as an orthotic device in clinical settings ( Table 4 ). There is level-2 evidence that it does not have a therapeutic effect (without switching on the stimulation) on speed of walking ( Table 4) . Most of these studies did the assessments in a clinical setting and may not reflect the effect of FES in daily life. In PwMS walking is more effortful and has a higher energy cost. There was evidence from one non-RCT that FES reduces energy expenditure. This was also supported by a qualitative study on effect of FES and AFO on gait. However, there was no significant differences between the patient reported fatigue between FES and AFO. 8 Gait analysis involves recording different aspects of gait like the force of movement, range of movements, and pattern of muscle activation using force plates, video cameras, and ambulatory electromyography. This offers advantages in assessing therapies which aim to improve gait function. There is level-3 evidence from four nonRCTs that FES improves kinematics of gait, especially ankle dorsiflexion (Table 4) .
Three RCTs used number of falls as a secondary outcome measure 10, 11, 16 and noted significant reduction in falls with FES. A qualitative study also reported the patient perception of safety and less trips and falls with FES. A large case series also noted similar effect. 20 There were no studies using falls as a primary outcome measure. Overall, there was level-2 and level-3 evidences that FES reduce number of falls and improve safety of walking in PwMS. There is evidence from a single RCT that FES improved activities of daily living in PwMS. 11 The study did not use blind participants or assessors. A key question for any intervention concerns comparison with other available technologies. Is FES better than standard orthotic devices, such as AFO and foot up splint for correcting foot drop in PwMS? There were no RCTs comparing FES with current standard orthotic interventions for foot drop in PwMS. There were only two small non-RCTs which are gait lab based and a qualitative study on patient perceptions comparing FES and AFO; none of which did not find any significant difference between FES and AFO. 8, 12, 15 There were no RCTs comparing AFO and FES in PwMS.
There is one study on cost effectiveness of FES on PwMS. This study has applied the same QALY gain from stroke for MS and demonstrated cost effectiveness. 23 However, this makes the assumption that the QALY gain for MS is the same as in stroke. There were no studies on the cost effectiveness of AFO.
CONClUSION
This review found level-1 evidence that FES has an orthotic effect on speed of walking and level-2 evidence that it reduces falls in people with foot drop due to MS. Most of the studies on FES were done in gait laboratories and used laboratory-based outcome measures like speed of walking and energy expenditure which do not reflect the patients' experience with the use of FES in the community. There is no evidence that FES is better than AFO. Given the potential for FES to improve mobility for PwMS and provide a cost-effective alternative to current standard care, there is an urgent need for a comprehensive trial for this intervention. An adequately powered multicenter RCT in order to evaluate this technology and compare FES with current standard care (AFO/foot up splint) is required. The trial should use a mixed method design incorporating a comprehensive range of measures, including patient reported outcome measures, physical activity monitoring, and cost effectiveness.
Key Practice Points
In PwMS and foot drop:
FES has an orthotic effect on speed of walking. FES has no therapeutic effect on speed of walking FES reduces number of trips and falls and improves activities of daily living There is only weak evidence on cost effectiveness of FES. There is no evidence that FES is better than AFO
